SKAN Group Unveils Growth Strategy and New Services at Capital Markets Day

SKAN Group AG ( (CH:SKAN) ) has provided an update.

SKAN Group AG held its first Capital Markets Day, highlighting its growth strategy and the introduction of Pre-Approved Services. The company aims to expand market leadership through investments in key competencies, innovation, and digital transformation. SKAN plans to increase revenue from aftermarket services and consumables, with a focus on maintaining its unique corporate culture. The new Pre-Approved Services facility will allow customers to conduct early stability tests for drug approval, significantly reducing time to market and providing a competitive edge.

The most recent analyst rating on (CH:SKAN) stock is a Buy with a CHF92.00 price target. To see the full list of analyst forecasts on SKAN Group AG stock, see the CH:SKAN Stock Forecast page.

More about SKAN Group AG

SKAN Group AG operates in the isolator technology industry, focusing on providing process solutions for aseptic filling and related services. The company benefits from structural growth drivers such as demographic changes, advancements in biotechnology, and the increasing trend towards injectable drugs. SKAN is recognized as a market leader due to its reputation for quality, technological leadership, and extensive service network.

Average Trading Volume: 14,100

Current Market Cap: CHF1.54B

Find detailed analytics on SKAN stock on TipRanks’ Stock Analysis page.